Chudnovsky Yekaterina — SEC Form 4 filings
SEC reporting owner CIK 1979324. 11 Form 4 filings on record with FilingPulse; latest filed 2026-09-02.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-03-20 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Elicio Therapeutics, Inc. (ELTX) | Director, 10% owner | 8 | — | — | 10 |
| Immix Biopharma, Inc. (IMMX) | Director | 3 | — | — | 4 |
Form 4 filings — Chudnovsky Yekaterina
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-02 | 4 | Elicio Therapeutics, Inc. (ELTX) | Grant/award (A): 21,750 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | Immix Biopharma, Inc. (IMMX) | Grant/award (A): 6,250 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2025-06-23 | 4 | Immix Biopharma, Inc. (IMMX) | Grant/award (A): 33,000 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Elicio Therapeutics, Inc. (ELTX) jointly with GKCC, LLC | Grant/award (A): 103,225 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | Elicio Therapeutics, Inc. (ELTX) | Grant/award (A): 7,900 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | Elicio Therapeutics, Inc. (ELTX) jointly with GKCC, LLC | Conversion (C): 3,500,573 @ $5.81 · Conversion (C): 3,442,341 (derivative) @ $5.81 | EDGAR |
| 2024-11-25 | 4 | Elicio Therapeutics, Inc. (ELTX) | Grant/award (A): 4,100 (derivative) @ $0 | EDGAR |
| 2024-08-14 | 4 | Elicio Therapeutics, Inc. (ELTX) jointly with GKCC, LLC | Purchase (P): 3,442,341 (derivative) @ $5.81 | EDGAR |
| 2024-07-02 | 4 | Elicio Therapeutics, Inc. (ELTX) jointly with GKCC, LLC | Purchase (P): 1,600,000 (derivative) @ $0 · Purchase (P): 1,600,000 (derivative) @ $4.99 | EDGAR |
| 2024-06-21 | 4 | Immix Biopharma, Inc. (IMMX) | Grant/award (A): 33,000 (derivative) @ $0 | EDGAR |
| 2024-03-20 | 4 | Elicio Therapeutics, Inc. (ELTX) jointly with GKCC, LLC | Purchase (P): 1,032,702 (derivative) @ $5.81 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1979324 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →